Cargando…
Dextran sulfate as a drug delivery platform for drug‐coated balloons: Preparation, characterization, in vitro drug elution, and smooth muscle cell response
Drug‐coated balloons (DCBs) have now emerged as a promising approach to treat peripheral artery disease. However, a significant amount of drug from the balloon surface is lost during balloon tracking and results in delivering only a subtherapeutic dose of drug at the diseased site. Hence, in this st...
Autores principales: | Lamichhane, Sujan, Anderson, Jordan, Remund, Tyler, Kelly, Patrick, Mani, Gopinath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054853/ https://www.ncbi.nlm.nih.gov/pubmed/26227252 http://dx.doi.org/10.1002/jbm.b.33494 |
Ejemplares similares
-
Drug-eluting balloon: is it useful?
por: Laksono, Sidhi, et al.
Publicado: (2020) -
In vivo angioscopy evaluation of drug-eluting stent occlusion treated with drug-coated balloon
por: Horikoshi, Takeo, et al.
Publicado: (2023) -
Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019) -
Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
por: Hirose, Masaki, et al.
Publicado: (2023) -
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2022)